
TSE:L
This summary was created by AI, based on 13 opinions in the last 12 months.
Loblaw Companies Ltd, the largest food and drug retailer in Canada, has garnered mixed reviews from analysts, with many acknowledging its defensive nature and solid market position. Experts appreciate the growth after the acquisition of Shoppers Drug Mart, contributing to strong profitability and free cash flow. The company faces challenges from growing competition, particularly from Walmart and Costco, but its private label offerings have proven resilient during inflationary periods. While some analysts highlight the current high valuation and express concerns over sustainability, the overall sentiment suggests it remains a core defensive portfolio choice amid economic uncertainty.
Just reported a weak quarter. Earnings were down. Having distribution problems as they switch over to Great Canadian Super stores. Their margins are still the best by far. Feels there's another tough quarter coming, but they are good operators and will eventually get it fixed. Has been buiying on weakness.